Processing Aid · CAS 8031-18-3

Fullers Earth

FDA status: Approved. EU: not separately listed. No U.S. state has enacted a specific ban yet.

Low Risk
Score 4 of 5
Fullers Earth: 4/5 (Low Risk)

According to the U.S. Food and Drug Administration, Fullers Earth is FDA-approved, and no U.S. state has moved to restrict it independently of federal policy.

Browse all Processing Aid additives →

The verdict

Fullers Earth is FDA-approved, and no U.S. state has moved to restrict it.

4/5
Low Risk
Approved
FDA status
-
EU status
0
state regulations

Fullers Earth: the CAS-identified regulatory record

Fullers Earth: no OFF product match; CAS 8031-18-3 is the lead registry handle on this row.

Property Value Source
CAS Number 8031-18-3 CAS Registry
FDA Status Approved FDA SAFFA
EU Status Not separately listed EC 1333/2008
E-Number - EU additive register
Category Processing Aid FDA functional class
Composite Safety Score 4 / 5 (Low Risk) PlainIngredients methodology
EFSA ADI Not in our EFSA data EFSA scientific opinion
U.S. State Actions 0 states State legislative records
Tracked Products Not yet tracked Open Food Facts (US)

Values reflect official agency classifications as published by the U.S. Food and Drug Administration and the European Union's regulatory framework. See our methodology for scoring details.

Fullers Earth: what it is

Fullers Earth (CAS 8031-18-3) is an FDA-regulated food substance used as processing aid.

Common Uses

processing aid

Catalog-profile peer axes

Fullers Earth among its nationwide catalog-profile peers

Product-count (0) and safety-score (4/5) peer columns, disjoint link sets.

Score 4/5 peers (≥50 OFF products)

Nearest other additives by PlainIngredients safety score (floored at ≥50 tracked products), distinct from the count row.

8 peers

Frequently Asked Questions

Is Fullers Earth safe to consume?

Fullers Earth scores 4/5 (Low Risk). FDA status is Approved. No OFF product match yet; the distinctive registry handle is CAS 8031-18-3, so this page leads with the chemical identity row rather than a shelf-prevalence claim.